Literature DB >> 18845324

Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells.

Trong Le1, Jody Tversky, Kristin L Chichester, Anja P Bieneman, Shau-Ku Huang, Robert A Wood, John T Schroeder.   

Abstract

BACKGROUND: Immature human blood monocytoid dendritic cells (mDCs) express high-affinity receptors for IgE (Fc epsilon RI), yet their exact function and regulation remain poorly understood.
OBJECTIVE: We sought to characterize Fc epsilon RI-dependent cytokine responses and their regulation in circulating human blood mDCs.
METHODS: Fc epsilon RI-dependent cytokine responses of circulating mDCs were studied by using anti-Fc epsilon RI alpha stimulation. Plasmacytoid dendritic cell (pDC) cross-regulation through Toll-like receptor 9 on these responses was investigated by examining the effects of exogenous IFN-alpha pretreatment and by coculturing pDCs and mDCs stimulated with CpG. Culture supernatants were analyzed by means of ELISA to determine cytokine levels. Cell markers were determined by means of flow cytometry.
RESULTS: mDCs express marked levels of Fc epsilon RI (net mean fluorescence intensity, 196 +/- 49; n = 4). After Fc epsilon RI-dependent activation in mDCs, TNF-alpha (2189 +/- 864 pg/10(6) mDCs, n = 3) levels were upregulated within 4 hours, whereas IL-10 (112 +/- 47 pg/10(6) mDCs, n = 3) levels were detectable only after 24 hours of incubation. After adding IL-10-neutralizing antibody, TNF-alpha Fc epsilon RI-dependent responses were significantly augmented (3903 +/- 197 pg/10(6) mDCs, P < .01, n = 3). Conversely, recombinant IL-10 dose-dependently inhibited Fc epsilon RI-mediated TNF-alpha responses up to 86% +/- 3% (n = 3, P < .001). Pretreatment of mDCs with IFN-alpha (100 U/mL) enhanced Fc epsilon RI-dependent secretion of IL-10 by 3.2-fold (183 +/- 11 pg/10(6) mDCs, n = 4) compared with that seen in untreated cells (57 +/- 33 pg/10(6) mDCs, P < .001, n = 4). In pDC/mDC cocultures pretreated with CpG, Fc epsilon RI-dependent IL-10 secretion by mDCs was similarly augmented by 3-fold.
CONCLUSIONS: Autocrine secretion of IL-10, a critical autoregulator of Fc epsilon RI-dependent proinflammatory responses in mDCs, is cross-regulated by IFN-alpha, a major product of Toll-like receptor 9 responses in pDCs that normally promotes T(H)1 immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845324      PMCID: PMC2674243          DOI: 10.1016/j.jaci.2008.09.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  30 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  A weak signal for strong responses: interferon-alpha/beta revisited.

Authors:  T Taniguchi; A Takaoka
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

3.  Type I interferons attenuate T cell activating functions of human mast cells by decreasing TNF-alpha production and OX40 ligand expression while increasing IL-10 production.

Authors:  Tomoko Fujita; Naotomo Kambe; Takashi Uchiyama; Toshiyuki Hori
Journal:  J Clin Immunol       Date:  2006-09-19       Impact factor: 8.317

Review 4.  Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation.

Authors:  Hamida Hammad; Bart N Lambrecht
Journal:  J Allergy Clin Immunol       Date:  2006-05-19       Impact factor: 10.793

5.  Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.

Authors:  Peter S Creticos; John T Schroeder; Robert G Hamilton; Susan L Balcer-Whaley; Arouna P Khattignavong; Robert Lindblad; Henry Li; Robert Coffman; Vicki Seyfert; Joseph J Eiden; David Broide
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

6.  Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge.

Authors:  Kai Bratke; Marek Lommatzsch; Peter Julius; Michael Kuepper; Hans-Dieter Kleine; Werner Luttmann; J Christian Virchow
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

7.  Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy.

Authors:  F L Jahnsen; F Lund-Johansen; J F Dunne; L Farkas; R Haye; P Brandtzaeg
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.

Authors:  John T Schroeder; Kristin L Chichester; Anja P Bieneman
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

9.  Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9.

Authors:  J R Tversky; T V Le; A P Bieneman; K L Chichester; R G Hamilton; J T Schroeder
Journal:  Clin Exp Allergy       Date:  2008-03-01       Impact factor: 5.018

10.  Airway dendritic cell phenotypes in inflammatory diseases of the human lung.

Authors:  M Lommatzsch; K Bratke; A Bier; P Julius; M Kuepper; W Luttmann; J C Virchow
Journal:  Eur Respir J       Date:  2007-07-11       Impact factor: 16.671

View more
  11 in total

Review 1.  Cellular immune response parameters that influence IgE sensitization.

Authors:  Pamela A Frischmeyer-Guerrerio; John T Schroeder
Journal:  J Immunol Methods       Date:  2012-01-08       Impact factor: 2.303

2.  IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

Authors:  Jing Wang; Xiang Cheng; Mei-Xiang Xiang; Mervi Alanne-Kinnunen; Jian-An Wang; Han Chen; Aina He; Xinghui Sun; Yan Lin; Ting-Ting Tang; Xin Tu; Sara Sjöberg; Galina K Sukhova; Yu-Hua Liao; Daniel H Conrad; Lunyin Yu; Toshiaki Kawakami; Petri T Kovanen; Peter Libby; Guo-Ping Shi
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

3.  Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function.

Authors:  J R Tversky; A P Bieneman; K L Chichester; R G Hamilton; J T Schroeder
Journal:  Clin Exp Allergy       Date:  2010-01       Impact factor: 5.018

Review 4.  The role of FcεRI expressed in dendritic cells and monocytes.

Authors:  Jeoung-Sook Shin; Alexandra M Greer
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

5.  Dendritic cell and T cell responses in children with food allergy.

Authors:  P A Frischmeyer-Guerrerio; A L Guerrerio; K L Chichester; A P Bieneman; R A Hamilton; R A Wood; J T Schroeder
Journal:  Clin Exp Allergy       Date:  2010-09-05       Impact factor: 5.018

6.  IgE cross-linking critically impairs human monocyte function by blocking phagocytosis.

Authors:  David M Pyle; Victoria S Yang; Rebecca S Gruchalla; J David Farrar; Michelle A Gill
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

7.  Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy.

Authors:  Pamela A Frischmeyer-Guerrerio; Corinne A Keet; Anthony L Guerrerio; Kristin L Chichester; Anja P Bieneman; Robert G Hamilton; Robert A Wood; John T Schroeder
Journal:  Clin Immunol       Date:  2014-08-27       Impact factor: 3.969

Review 8.  Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases.

Authors:  Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2016-06       Impact factor: 10.793

Review 9.  Immunoglobulin E-Mediated Autoimmunity.

Authors:  Marcus Maurer; Sabine Altrichter; Oliver Schmetzer; Jörg Scheffel; Martin K Church; Martin Metz
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 10.  Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.

Authors:  Stefan Schülke
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.